Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Hidden Culprit in Optic Neuritis: Mitochondrial Complex I Deficiency Due to a Novel NDUFS1 Mutation.
CRISPR-Based Gene Therapy for Brain Disease.
Sex differences in healthcare use before the first multiple sclerosis-related demyelinating event.
Early rituximab and structured rehabilitation drive rapid functional restoration in steroid- and PLEX-refractory NMOSD: a case report.
Proteomic signatures of protected APOE ε4 carriers reveal causal pathways associated with delayed Alzheimer's disease onset.
Associations Between Neuromuscular Fatigue, Anxiety, and Peripheral Biomarkers of Neuronal Injury, Inflammation, and Mitochondrial Dysfunction in Treatment-Naïve Relapsing-Remitting Multiple Sclerosis.
Use of semaglutide and tirzepatide among people with multiple sclerosis.
An unrecognized mechanism of neuroprotection by microglial TIA1-mediated stress granules to prevent neuroinflammation and demyelination in experimental autoimmune encephalomyelitis mice through sequestering ApoE mRNA.
Proteomic Age Acceleration in Multiple Sclerosis Precedes Symptom Onset and Associates with Severity.
Distinct age-related pattern of mitochondrial somatic mutations across multiple sclerosis phenotypes.
The GPR17 agonist galinex restores oligodendrocyte maturation under inflammatory conditions.
Stage-Specific Molecular Cargo of Schwann Cell-Derived Extracellular Vesicles is Associated With Peripheral Nerve Repair.
Correlation study between inflammatory, nutritional and metabolic indicators and the risk of invasive ductal carcinoma of the breast.
Ultraviolet radiation and neurodegeneration: molecular mechanisms underlying dual neuroprotective and neurotoxic effects.
T cell-mediated immunodysregulation in multiple sclerosis: from pathogenic subsets to therapeutic advances.
Fluid biomarkers in multiple sclerosis: Indicators of disease activity, progression, and treatment response.
Tau Ablation Rewires Brain Cell Programs in Health and Restores Function in Disease.
Sex-Related Differences in Circular RNA Expression in Multiple Sclerosis: A Pilot Study.
EXPRESS: Brain Microvascular Endothelial Cells: Beyond a Barrier.
Cognitive impairment in multiple sclerosis: Where do we stand today?
A clustering-based approach to characterize autonomy profiles among multiple sclerosis patients: an application of the Qluster method in the FOCAL-MS2 study.
Causal Relationship Between Circulating Leukocyte Characteristics and Immune Cell Traits With Multiple Sclerosis Risk: A Two-Sample Bidirectional Mendelian Randomisation Study.
Dysregulation of the Schwann cell GABAergic system and Aβ-fibers conduction abnormalities in the sciatic nerve of the mdx mouse model of Duchenne muscular dystrophy.
Isolated Unilateral Optic Neuritis Secondary to Presumed Ocular Tuberculosis in an Immunocompetent Adult.
Interleukin-6 trans-signalling as a selectively targetable driver of neurodegeneration.
Pages
« first
‹ previous
…
822
823
824
825
826
827
828
829
830
…
next ›
last »